What is Avanos Medical's revenue?

Avanos Medical (AVNS) generated $715.9M in revenue over the trailing twelve months, up 3.9% year over year.

Is Avanos Medical profitable?

Avanos Medical is not currently profitable: it reported a net loss of $74.4M over the trailing twelve months, a -10.4% net margin.

What are Avanos Medical's profit margins?

Gross margin is 50.0% and operating margin is -9.1%, with a -10.4% net margin.

What is Avanos Medical's earnings per share?

Avanos Medical's diluted EPS over the trailing twelve months is $-1.60.

Where does Avanos Medical's income statement data come from?

Every line is extracted from Avanos Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Avanos Medical AVNS Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$701.2M+1.9%	$687.8M+2.2%	$673.3M-6.8%	$722.2M+23.0%
Total cost of revenue	$347.3M+13.3%	$306.5M+4.4%	$293.6M-5.6%	$310.9M+8.0%
Gross profit	$353.9M-7.2%	$381.3M+0.4%	$379.7M-7.7%	$411.3M+37.5%
Gross margin	50.5%-5.0pp	55.4%-1.0pp	56.4%-0.6pp	57%+6.0pp
Research and development	$23.3M-11.1%	$26.2M-3.7%	$27.2M-8.4%	$29.7M-2.9%
Selling, general and administrative	$315.6M-0.9%	$318.5M-4.9%	$335M+1.4%	$330.3M+15.8%
Compensation and benefits	$12.6M-8.7%	$13.8M-12.7%	$15.8M-0.6%	$15.9M+20.5%
Depreciation and amortization	$38.9M-14.5%	$45.5M-1.3%	$46.1M-3.4%	$47.7M+24.5%
Provision for credit losses	$800K+14.3%	$700K0.0%	$700K-73.1%	$2.6M—
Impairment charges	$0—	——	——	$7.8M-1.3%
Other operating expenses	$400K-89.7%	$3.9M+129%	-$13.3M-316%	-$3.2M—
Operating income	-$64.1M+83.8%	-$396.2M-9,533%	$4.2M-91.3%	$48.1M+224%
Operating margin	-9.1%+48.5pp	-57.6%-58.2pp	0.6%-6.0pp	6.7%+13.3pp
Interest expense	$7.8M-36.1%	$12.2M-18.7%	$15M+50.0%	$10M+203%
Interest income	$3.2M-37.3%	$5.1M+75.9%	$2.9M+142%	$1.2M+500%
Other income (expense), net	——	——	——	——
Gain (loss) on disposal of assets	$0—	$0+100%	-$70.8M—	$0—
Income before income taxes	-$67.4M+83.3%	-$403.3M—	——	$39.3M+193%
Income tax expense	$6.7M+139%	-$17M—	——	$8.4M—
Net income	-$72.9M+81.4%	-$392.1M—	——	$50.5M+702%
Net margin	-10.4%+46.6pp	-57%—	——	7%+5.9pp
Diluted earnings per share	-$1.57+81.6%	-$8.53—	——	$1.06+715%
Basic earnings per share	-$1.57+81.6%	-$8.53—	——	$1.09+679%
Weighted-average shares, diluted	185.8M+0.1%	185.6M-0.6%	186.8M-1.5%	189.7M-1.9%
Weighted-average shares, basic	185.1M+0.5%	184.1M-1.4%	186.8M-0.7%	188.1M-2.2%
Pre-tax stock-based compensation cost	$12.6M-8.7%	$13.8M-12.7%	$15.8M-0.6%	$15.9M+20.5%
Stock options excluded as their inclusion would be anti-dilutive (in shares)	9.3M+60.3%	5.8M-28.4%	8.1M+11.0%	7.3M+37.7%
Capital investments accrued but not yet paid	$1.6M-71.4%	$5.6M+64.7%	$3.4M-12.8%	$3.9M-30.4%
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	——	——	——	——
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$60.3M+85.3%	-$409.7M—	——	$48.5M+7,983%
Federal	$7.3M-17.0%	$8.8M+138%	$3.7M-24.5%	$4.9M+132%
Foreign	$4.6M-13.2%	$5.3M+32.5%	$4M+135%	$1.7M+30.8%
Current State And Local Tax Expense Benefit	$2.6M-45.8%	$4.8M+100%	$2.4M0.0%	$2.4M+400%
Federal	-$6.8M+76.3%	-$28.7M-486%	-$4.9M-22.5%	-$4M-205%
Deferred Foreign Income Tax Expense Benefit	$200K+122%	-$900K+30.8%	-$1.3M-225%	-$400K-500%
State	-$1.2M+81.0%	-$6.3M-232%	-$1.9M-417%	$600K+700%
Defined Benefit Plan, Net Periodic Benefit Cost (Credit)	$600K+500%	$100K-88.9%	$900K+28.6%	$700K-12.5%
Defined Contribution Plan Cost Recognized	$5.9M0.0%	$5.9M-10.6%	$6.6M+1.5%	$6.5M-1.5%
Depreciation	$19.7M-3.0%	$20.3M+5.7%	$19.2M+3.8%	$18.5M+8.8%
Effect of exchange rate changes on cash, cash equivalents and restricted cash	$5.3M+229%	-$4.1M—	——	——
Income taxes at U.S. statutory rate of 21%	——	——	——	——
Cross-border (branch), net of FTC	-$300K—	——	——	——
Cross-border (branch), net of FTC	——	——	——	——
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	——	——	——	——
Foreign operations	——	——	——	——
Global Intangible Low-taxed Income, net of credits	$400K—	——	——	——
Global Intangible Low-taxed Income, net of credits	——	——	——	——
Nondeductible goodwill impairment	$16.2M—	——	——	——
Nondeductible officer’s compensation	$2M—	——	——	——
Nondeductible officer’s compensation	——	——	——	——
Nondeductible goodwill impairment	——	——	——	——
Excess tax benefits associated with employee equity plans (in percent)	——	——	——	——
Excess tax benefits associated with employee equity plans	$1.1M—	——	——	——
State income taxes – net of federal income tax benefit	——	——	——	——
Changes in unrecognized tax benefits	——	——	——	——
Effective Income Tax Rate Reconciliation Tax Credits Research	——	——	——	——
Gain (Loss) on Disposition of Assets	——	——	——	——
Gain on sale of business and assets	$0—	$0+100%	-$70.8M—	$0—
Gain Loss On Sale Of Property Plant Equipment	-$9.3M-675%	-$1.2M+36.8%	-$1.9M-72.7%	-$1.1M—
Gain on termination of lease	——	$6.9M—	——	——
Gain (loss) recognized on lease modification	$6.9M+200%	-$6.9M—	——	——
Goodwill And Intangible Asset Impairment	$77M—	——	$0—	$0—
Income Loss From Continuing Operations Before Income Taxes Domestic	-$82.8M+80.4%	-$421.5M-2,336%	-$17.3M-180%	$21.6M+149%
Income Loss From Continuing Operations Before Income Taxes Foreign	$16.6M-8.8%	$18.2M+93.6%	$9.4M+84.3%	$5.1M+155%
Federal taxes	$1.2M—	——	——	——
State taxes	$4.1M—	——	——	——
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	$500K—	——	——	——
Income Tax Reconciliation Change In Enacted Tax Rate	$0—	——	——	——
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	-$13.9M—	——	——	——
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	-$100K—	——	——	——
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	$1M—	——	——	——
Changes in unrecognized tax benefits	$0—	——	——	——
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount	$1.5M—	——	——	——
Income Taxes Paid, Net	$14.1M—	——	——	——
Increase (Decrease) in Accounts Payable, Trade	——	——	——	$35.4M—
Increase (Decrease) in Accounts Receivable	-$33.9M—	——	——	——
Accrued liabilities	——	——	——	——
Increase (Decrease) in Inventories	-$200K+99.5%	-$39M-730%	-$4.7M—	——
Increase (Decrease) in Prepaid Expense and Other Assets	-$1.4M+90.6%	-$14.9M-176%	$19.6M—	——
Interest Paid, Excluding Capitalized Interest, Operating Activity	$6.5M-43.5%	$11.5M-21.8%	$14.7M+81.5%	$8.1M+170%
Inventory Write Down	$9.4M+67.9%	$5.6M+3.7%	$5.4M-37.2%	$8.6M—
Korea tax audit assessment, payment	——	——	——	——
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	-$37M+24.6%	-$49.1M+47.9%	-$94.2M—	——
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$60.6M-120%	-$27.5M-227%	$21.6M+116%	-$135.4M-545%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$74.7M-25.8%	$100.7M+211%	$32.4M-64.4%	$90.9M+4.1%
Number of operating segments	——	——	——	——
Number of reportable segments	——	——	——	——
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent	$200K+167%	-$300K-200%	$300K—	——
Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent	$0+100%	-$100K—	$0—	——
Foreign currency translation	$13M+173%	-$17.9M-297%	$9.1M—	——
Change in net unrealized gain (loss) on derivative instruments	-$200K—	$0—	$0—	$0—
Other comprehensive income/(loss)	$12.6M+172%	-$17.6M-300%	$8.8M—	——
All other operating activities	-$10.4M+73.6%	-$39.4M-75.9%	-$22.4M—	$0—
Payments for civil penalty	$0—	$0—	$0—	$0-100%
Payments for Repurchase of Common Stock	$3.3M-74.2%	$12.8M-33.0%	$19.1M-58.0%	$45.5M+296%
Payments (Proceeds) For Income Taxes	-$14.1M-327%	-$3.3M+86.0%	-$23.6M-914%	$2.9M-93.6%
Payments To Acquire Businesses And Interest In Affiliates	——	——	——	——
Payments to Acquire Productive Assets	$31.6M+77.5%	$17.8M0.0%	$17.8M-7.8%	$19.3M-8.1%
Proceeds from RH divestiture post-closing settlement	$0-100%	$2.1M—	$0—	$0—
Cash received from option exercises	——	——	——	$1.7M—
Net additions (releases) charged to costs and expenses	$800K+14.3%	$700K0.0%	$700K-73.1%	$2.6M—
Repayments of Lines of Credit	——	$45M—	——	$170M—
Repayments of Secured Debt	$9.4M+9.3%	$8.6M+83.0%	$4.7M-96.3%	$126.6M—
Stock-based compensation	$12.6M-8.7%	$13.8M-12.7%	$15.8M-0.6%	$15.9M+20.5%
Granted (in shares)	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period	——	——	——	——
Options canceled (in dollars per share)	——	——	——	——
Granted (in shares)	——	——	——	——
Exercised (in shares)	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period	——	——	——	——
Issuance of common stock upon the exercise or redemption of share-based awards and from employee stock purchase plan, net of treasury stock purchased	——	——	-$2.7M—	——
Stock issued for employee stock purchase plan	$700K-41.7%	$1.2M—	——	——
Prior years	——	——	$10M—	——
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$800K+300%	-$400K+91.5%	-$4.7M-883%	$600K-57.1%
EBIT	-$64.1M+83.8%	-$396.2M-9,533%	$4.2M-91.3%	$48.1M+224%
EBITDA	-$25.2M+92.8%	-$350.7M-797%	$50.3M-47.5%	$95.8M+24,050%
EBITDA	-$25.2M+92.8%	-$350.7M-797%	$50.3M-47.5%	$95.8M+24,050%
EBITDA margin	-3.6%+47.4pp	-51%-58.5pp	7.5%-5.8pp	13.3%+13.3pp
EBIT	-$64.1M+83.8%	-$396.2M-9,533%	$4.2M-91.3%	$48.1M+224%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Avanos Medical.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avanos Medical's revenue?: Avanos Medical (AVNS) generated $715.9M in revenue over the trailing twelve months, up 3.9% year over year.
Is Avanos Medical profitable?: Avanos Medical is not currently profitable: it reported a net loss of $74.4M over the trailing twelve months, a -10.4% net margin.
What are Avanos Medical's profit margins?: Gross margin is 50.0% and operating margin is -9.1%, with a -10.4% net margin.
What is Avanos Medical's earnings per share?: Avanos Medical's diluted EPS over the trailing twelve months is $-1.60.
Where does Avanos Medical's income statement data come from?: Every line is extracted from Avanos Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.